Colivet Quick Pump 8 mg/ml or. susp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

colivet quick pump 8 mg/ml or. susp.

prodivet pharmaceuticals sa-nv - colistin sulfate 8 mg/ml - oral suspension - 8 mg/ml - colistin sulfate 8 mg - colistin - pig

Colivet SF 500 500000 IU/ml inj. sol. i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

colivet sf 500 500000 iu/ml inj. sol. i.m. vial

prodivet pharmaceuticals sa-nv - colistin sulfate 500000 iu/ml - solution for injection - 500000 iu/ml - colistin sulfate 500000 iu/ml - colistin - pig; cattle

Promycine 200000 IU/g premix medic. feeding stuff Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

promycine 200000 iu/g premix medic. feeding stuff

v.m.d. sa-nv - colistin sulfate 200000 iu/g - premix for medicated feeding stuff - 200.000 iu/g - colistin sulfate 200000 iu/g - colistin - poultry; pig

Promycine 400000 IU/g premix medic. feeding stuff Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

promycine 400000 iu/g premix medic. feeding stuff

v.m.d. sa-nv - colistin sulfate 400000 iu/g - premix for medicated feeding stuff - 400.000 iu/g - colistin sulfate 400000 iu/g - colistin - pig

Promycine Bolus 3 MIU/bolus tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

promycine bolus 3 miu/bolus tabl.

v.m.d. - colistin sulfate 3000000 iu - tablet - 3 miu/bolus - colistin sulfate 3000000 iu - colistin - cattle

Promycine Pulvis 1000 IU/mg or. sol. (pwdr.) jar Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

promycine pulvis 1000 iu/mg or. sol. (pwdr.) jar

v.m.d. - colistin sulfate 1000000 iu/g - powder for oral solution - 1000 iu/mg - colistin sulfate 1000000 iu/g - colistin - poultry; cattle; pig

Promycine Pulvis 4800 IU/mg pwdr. for drinking water/milk jar Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

promycine pulvis 4800 iu/mg pwdr. for drinking water/milk jar

v.m.d. sa-nv - colistin sulfate 4800000 iu/g - powder for use in drinking water/milk - 4800 iu/mg - colistin sulfate 4800000 iu/g - colistin - cattle; pig

COLISTIN APSA 1,200,000 IU/G PREMIX FOR MEDICATED FEEDING STUFF FOR PIGS Ireland - English - HPRA (Health Products Regulatory Authority)

colistin apsa 1,200,000 iu/g premix for medicated feeding stuff for pigs

andres pintaluba s.a. - colistin (as sulfate) - premix for med.feedstuffs - 1,200,000 international unit - colistin - porcine - antibiotics

COLISTIN APSA 1,200,000 IU/g Premix for medicated feeding stuff for pigs Ireland - English - HPRA (Health Products Regulatory Authority)

colistin apsa 1,200,000 iu/g premix for medicated feeding stuff for pigs

andres pintaluba s.a. - colistin - premix for medicated feeding stuff - 1,200,000 international unit(s)/gram - colistin - pigs - antibiotics

COLISTIN LINK colistimethate sodium (equivalent to colistin 150 mg, 4,500,000 IU)  powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

colistin link colistimethate sodium (equivalent to colistin 150 mg, 4,500,000 iu) powder for injection vial

link medical products pty ltd t/a link pharmaceuticals - colistimethate sodium (equivalent: colistin, qty iu) - injection, powder for - excipient ingredients: - colistin link parental is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli. it is particularly indicated when the infection is caused by sensitve strains of pseudomonas aeruginosa. this antibiotic is not indicated for infections due to proteus and neisseria. colistin link parental has proven clinically effective in treatment of infections due to the following gram-negative organisms: enterobacter aerogenes, escherichia coli, klebsiella pneumoniae and pseudomonas aeruginosa. pending results of appropriate bacterialogic cultures and sensitvity tests, colistin link parental may be used to initiate therapy in serious infections that are suspected due to gram-negative organisms.